Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company. From its 2 employees, 5,000 square foot beginning, the company has grown to employ over 10,000 people in research, development, manufacturing and distribution facilities world-wide. The Canadian operations of the Apotex Group of Companies has over 6,000 employees. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year - the largest amount of any pharmaceutical company in this country. The company's pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe.
Apotex Line of Business :
1. Global Generics: Responsible for the delivery of the generics portfolio arising out of the Apotex group of companies (Apotex Inc., ARPL, Aveva) and third parties to all global markets.
2. Apobiologix: Responsible for the development, manufacturing and global commercialization of Biosimilars and other specialty products made by Apotex or supplied by third parties.
3. ApoPharma: Responsible for the development of our innovative product portfolio. Two products are: Ferriprox (Deferiprone) and Alkeran (Melphalan).
4. Global Active Pharmaceutical Ingredients (API): Responsible for delivering API to the Apotex Group (either from the Pharmachem Group of companies or from third party suppliers) and sales of select API€™s to other global customers.
Apotex Research Private Limited (ARPL), the Indian Research & Development wing of Apotex Inc. was established in the year 2004 in Bangalore, India. Today, ARPL's expertise covers Product Development, Product Evaluation and Analytical Support to PD and Commercial group of Apotex Inc., Manufacturing, Site Transfers, Bio Equivalence and Clinical Research, Biosimilars, and API.
At ARPL, we truly believe that our products speak for us! With our successful track record, enabled by our high-end machineries and instruments and sharpest minds in the business, we are fast becoming one of the brightest spots for pharma growth. As a part of this dynamic team, you will get to work in our state-of-the-art facilities, which include sophisticated equipments, high standard processes and the opportunity to work alongside some of the world's top professionals.
ARPL is trusted and approved by prestigious regulatory bodies like US FDA, MHRA (UK), TGA (Australia), WHO and Polish Regulatory Authorities among others.